These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 6352025

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Effect of prostaglandin-mediated platelet-suppressant drugs on acute cardiovascular catastrophes.
    Sherry S.
    Adv Prostaglandin Thromboxane Leukot Res; 1982; 10():173-210. PubMed ID: 6216782
    [No Abstract] [Full Text] [Related]

  • 3. A perspective on platelet-suppressant drug treatment in coronary artery and cerebrovascular disease.
    Genton E.
    Circulation; 1980 Dec; 62(6 Pt 2):V111-21. PubMed ID: 6108166
    [No Abstract] [Full Text] [Related]

  • 4. A critical appraisal of the clinical efficiency of anti-platelet drugs.
    Lecompte T, Samama M.
    Agents Actions Suppl; 1986 Dec; 20():203-14. PubMed ID: 3544741
    [No Abstract] [Full Text] [Related]

  • 5. Platelet-inhibitory therapy in reconstructive arterial surgery.
    McCollum CN, Goldman M.
    Adv Prostaglandin Thromboxane Leukot Res; 1985 Dec; 13():301-9. PubMed ID: 3159216
    [No Abstract] [Full Text] [Related]

  • 6. Clinical trials in thrombosis: secondary prevention of myocardial infarction.
    Klimt CR, Doub PH, Doub NH.
    Thromb Haemost; 1976 Feb 29; 35(1):49-56. PubMed ID: 785688
    [Abstract] [Full Text] [Related]

  • 7. Clinical trials of antiplatelet drug therapy in acute myocardial infarction, unstable angina, and aortocoronary bypass surgery.
    Cairns JA.
    Cardiovasc Clin; 1987 Feb 29; 18(1):231-46. PubMed ID: 3300983
    [No Abstract] [Full Text] [Related]

  • 8. Summary of ongoing clinical trials of platelet-active drugs in cardiovascular disease.
    Passamani ER.
    Circulation; 1980 Dec 29; 62(6 Pt 2):V106-10. PubMed ID: 7002348
    [Abstract] [Full Text] [Related]

  • 9. Secondary prevention of myocardial infarction.
    Davies JA.
    Int J Clin Pharmacol Res; 1985 Dec 29; 5(5):303-7. PubMed ID: 3905632
    [Abstract] [Full Text] [Related]

  • 10. [Clinical application and evaluation of anti-platelet agents].
    Yasunaga K.
    Nihon Rinsho; 1978 Dec 10; 36(12):3884-94. PubMed ID: 372628
    [No Abstract] [Full Text] [Related]

  • 11. Antithrombotic effects of drugs which suppress platelet function: their potential in prevention growth of tumour cells.
    Turpie AG.
    Prog Clin Biol Res; 1982 Dec 10; 89():31-62. PubMed ID: 7051035
    [Abstract] [Full Text] [Related]

  • 12. Platelet inhibitors in the treatment of thrombosis.
    Hirsh J.
    Clin Invest Med; 1978 Dec 10; 1(3-4):191-206. PubMed ID: 391458
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Critical evaluation of platelet-inhibiting drugs in thrombotic disease.
    Harker LA, Hirsh J, Gent M, Genton E.
    Prog Hematol; 1975 Dec 10; 9():229-54. PubMed ID: 766074
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Platelet function inhibitors: their clinical use.
    Fuster V, Didisheim P.
    Adv Intern Med; 1978 Dec 10; 23():251-64. PubMed ID: 343540
    [No Abstract] [Full Text] [Related]

  • 18. Efficacy of antiplatelet drugs in the maintenance of aortocoronary vein bypass graft patency.
    Gitler B, Gitler ES.
    Am Heart J; 1983 Sep 10; 106(3):563-70. PubMed ID: 6410893
    [No Abstract] [Full Text] [Related]

  • 19. Antiplatelet therapy.
    Sloan RW.
    Am Fam Physician; 1981 Oct 10; 24(4):129-34. PubMed ID: 7025599
    [Abstract] [Full Text] [Related]

  • 20. [Prophylactic value of platelet anti-aggregants in coronary disease].
    Verstraete M.
    Clin Ter; 1979 Oct 31; 91(2):117-27. PubMed ID: 396098
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.